Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.800
-0.290 (-7.09%)
Nov 13, 2026, 4:00 PM EST - Market closed
Camp4 Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 124.52 | 109.52 | 64.04 | 38.38 | 83.19 |
Cash & Short-Term Investments | 124.52 | 109.52 | 64.04 | 38.38 | 83.19 |
Cash Growth | 65.47% | 71.02% | 66.86% | -53.86% | - |
Accounts Receivable | - | 0.16 | - | - | - |
Other Receivables | 0.22 | - | 0.11 | 0.44 | 0.68 |
Receivables | 0.22 | 0.16 | 0.11 | 0.44 | 0.68 |
Prepaid Expenses | 0.03 | 0.56 | 0.59 | 0.36 | 0.16 |
Restricted Cash | 0.73 | 1.35 | - | - | - |
Other Current Assets | 2.04 | 2.52 | 1.65 | 0.83 | 0.38 |
Total Current Assets | 127.54 | 114.1 | 66.38 | 40.01 | 84.41 |
Property, Plant & Equipment | 5.52 | 2.74 | 9.87 | 13.31 | 16.79 |
Other Long-Term Assets | 0.96 | 0.98 | 2.05 | 1.62 | 1.35 |
Total Assets | 134.01 | 117.81 | 78.31 | 54.95 | 102.55 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 0.76 | 0.18 | 1.21 | 1.04 | 2.15 |
Accrued Expenses | 6.81 | 5.54 | 4.3 | 3.01 | 3.17 |
Current Portion of Long-Term Debt | - | 0.03 | 0.18 | 0.41 | - |
Current Portion of Leases | 1.63 | 0.29 | 2.99 | 3.06 | 2.37 |
Current Unearned Revenue | 10.5 | 9.39 | 0.39 | - | - |
Other Current Liabilities | 0.17 | 0.09 | 0.54 | 0.29 | 0.26 |
Total Current Liabilities | 19.87 | 15.51 | 9.6 | 7.81 | 7.95 |
Long-Term Debt | - | - | - | 0.09 | - |
Long-Term Leases | 4.83 | 1.69 | 5.49 | 8.64 | 10.03 |
Long-Term Unearned Revenue | 2.18 | 8.11 | - | - | - |
Other Long-Term Liabilities | 0.05 | 44.79 | 0.07 | 0 | -0.04 |
Total Liabilities | 26.92 | 70.1 | 15.16 | 16.53 | 17.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.01 | 0.01 | 0 | 0 | 0 |
Additional Paid-In Capital | 480.06 | 339.85 | 274.9 | 36.23 | 33.14 |
Retained Earnings | -372.97 | -292.16 | -211.75 | -159.96 | -110.67 |
Total Common Equity | 107.09 | 47.7 | 63.14 | -123.73 | -77.53 |
Shareholders' Equity | 107.09 | 47.7 | 63.14 | 38.42 | 84.62 |
Total Liabilities & Equity | 134.01 | 117.81 | 78.31 | 54.95 | 102.55 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 6.45 | 2 | 8.66 | 12.18 | 12.4 |
Net Cash (Debt) | 118.07 | 107.52 | 55.38 | 26.2 | 70.8 |
Net Cash Growth | 71.34% | 94.16% | 111.38% | -63.00% | - |
Net Cash Per Share | 1.90 | 3.54 | 11.81 | 66.33 | 226.69 |
Filing Date Shares Outstanding | 62.75 | 51.92 | 20.15 | 0.46 | 0.31 |
Total Common Shares Outstanding | 62.75 | 51.9 | 20.15 | 0.46 | 0.31 |
Working Capital | 107.67 | 98.58 | 56.79 | 32.21 | 76.46 |
Book Value Per Share | 1.71 | 0.92 | 3.13 | -268.57 | -248.26 |
Tangible Book Value | 107.09 | 47.7 | 63.14 | -123.73 | -77.53 |
Tangible Book Value Per Share | 1.71 | 0.92 | 3.13 | -268.57 | -248.26 |
Machinery | 4.73 | 5.57 | 5.57 | 4.78 | 4.17 |
Leasehold Improvements | 0.02 | 4.52 | 4.52 | 4.52 | 4.52 |